Eli Lilly Concord

Timely delivery of a new facility to support commercial production of Mounjaro and Zepbound medications and allow Lilly to meet their goals of improving health of their clients.

The vision for this 75-acre greenfield site encompasses site development and construction of core and shell structures for seven specialized buildings. The multi-phase development includes administrative offices, QC laboratories, logistics, parenteral filling, device assembly, packaging facilities, and central utilities. The fit-out of Buildings 1, 5, and 7 integrates administrative spaces, waste management, and maintenance operations, while Buildings 2, 4, and 6 focus on advanced device assembly and packaging.

Challenges with supply chains, complex coordination among global equipment providers, and the management of multiple general contractors heightened the complexity of an ambitious goal. Centered around a shared vision, the team leveraged strategic planning, creative collaboration, and phased turnovers to enable early move-ins, accelerated schedules, and seamless integration of diverse user needs—paving the way for world-class pharmaceutical innovation and impact worthy of the Eli Lilly name.

Concord, NC

1,300,000 SF

2026